Cargando…
Herbal Medicines for Irinotecan-Induced Diarrhea
Irinotecan (CPT-11), a water-soluble derivative of camptothecin, belongs to the class of DNA topoisomerase I inhibitors and has been approved worldwide for the treatment of advanced colorectal cancer, lung cancer, and malignant lymphoma. Although CPT-11-based chemotherapy is widely used, severe gast...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450188/ https://www.ncbi.nlm.nih.gov/pubmed/30983992 http://dx.doi.org/10.3389/fphar.2019.00182 |
_version_ | 1783408991127207936 |
---|---|
author | Tang, Liu Li, Xiaolei Wan, Liping Xiao, Yao Zeng, Xin Ding, Hong |
author_facet | Tang, Liu Li, Xiaolei Wan, Liping Xiao, Yao Zeng, Xin Ding, Hong |
author_sort | Tang, Liu |
collection | PubMed |
description | Irinotecan (CPT-11), a water-soluble derivative of camptothecin, belongs to the class of DNA topoisomerase I inhibitors and has been approved worldwide for the treatment of advanced colorectal cancer, lung cancer, and malignant lymphoma. Although CPT-11-based chemotherapy is widely used, severe gastrointestinal (GI) toxicity, especially late-onset diarrhea, is a common adverse reaction, limiting clinical application of the drug. The incidence of grade 3 or 4 diarrhea is high, with 20–40% of CPT-11-treated patients experiencing this adverse effect. High-dose loperamide and octreotide are generally recommended for treatment of CPT-11-induced diarrhea. However, in clinical practice, loperamide is associated with a significant failure rate and the beneficial effects of octreotide are controversial. An accumulating number of recent studies have suggested that medicinal herbs and their derived phytocompounds may be effective complementary treatments for CPT-11-induced diarrhea. In this mini-review, we briefly summarize currently available literatures regarding the formulae and herbs/natural products used as adjuvants in animal and clinical studies for the treatment of diarrhea caused by CPT-11. |
format | Online Article Text |
id | pubmed-6450188 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64501882019-04-12 Herbal Medicines for Irinotecan-Induced Diarrhea Tang, Liu Li, Xiaolei Wan, Liping Xiao, Yao Zeng, Xin Ding, Hong Front Pharmacol Pharmacology Irinotecan (CPT-11), a water-soluble derivative of camptothecin, belongs to the class of DNA topoisomerase I inhibitors and has been approved worldwide for the treatment of advanced colorectal cancer, lung cancer, and malignant lymphoma. Although CPT-11-based chemotherapy is widely used, severe gastrointestinal (GI) toxicity, especially late-onset diarrhea, is a common adverse reaction, limiting clinical application of the drug. The incidence of grade 3 or 4 diarrhea is high, with 20–40% of CPT-11-treated patients experiencing this adverse effect. High-dose loperamide and octreotide are generally recommended for treatment of CPT-11-induced diarrhea. However, in clinical practice, loperamide is associated with a significant failure rate and the beneficial effects of octreotide are controversial. An accumulating number of recent studies have suggested that medicinal herbs and their derived phytocompounds may be effective complementary treatments for CPT-11-induced diarrhea. In this mini-review, we briefly summarize currently available literatures regarding the formulae and herbs/natural products used as adjuvants in animal and clinical studies for the treatment of diarrhea caused by CPT-11. Frontiers Media S.A. 2019-03-29 /pmc/articles/PMC6450188/ /pubmed/30983992 http://dx.doi.org/10.3389/fphar.2019.00182 Text en Copyright © 2019 Tang, Li, Wan, Xiao, Zeng and Ding. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Tang, Liu Li, Xiaolei Wan, Liping Xiao, Yao Zeng, Xin Ding, Hong Herbal Medicines for Irinotecan-Induced Diarrhea |
title | Herbal Medicines for Irinotecan-Induced Diarrhea |
title_full | Herbal Medicines for Irinotecan-Induced Diarrhea |
title_fullStr | Herbal Medicines for Irinotecan-Induced Diarrhea |
title_full_unstemmed | Herbal Medicines for Irinotecan-Induced Diarrhea |
title_short | Herbal Medicines for Irinotecan-Induced Diarrhea |
title_sort | herbal medicines for irinotecan-induced diarrhea |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450188/ https://www.ncbi.nlm.nih.gov/pubmed/30983992 http://dx.doi.org/10.3389/fphar.2019.00182 |
work_keys_str_mv | AT tangliu herbalmedicinesforirinotecaninduceddiarrhea AT lixiaolei herbalmedicinesforirinotecaninduceddiarrhea AT wanliping herbalmedicinesforirinotecaninduceddiarrhea AT xiaoyao herbalmedicinesforirinotecaninduceddiarrhea AT zengxin herbalmedicinesforirinotecaninduceddiarrhea AT dinghong herbalmedicinesforirinotecaninduceddiarrhea |